Séminaire - The use of insurance claims data to improve health care

Intervenant

• Thomas D. Szucs, MD, MPH, MBA, LLM, PhD
  • Professor and Chair of Pharmaceutical Medicine and Director of the European Center of Pharmaceutical Medicine at the University of Basel

Thomas Szucs is Professor and Chair of Pharmaceutical Medicine and Director of the European Center of Pharmaceutical Medicine at the University of Basel. He is practicing genomic medicine specialist and co-director of genomic medicine in the Hirslanden Group. Previously he was Chief Medical Officer and Chief Operating Officer of Hirslanden Holding, the largest private hospital chain in Switzerland. As an academic, he held appointments at the universities of Munich, Bayreuth, Milano and Zurich. In 2010 he received an honorary professorship of the University of Peking.

He has worked at F. Hoffman-La Roche, ultimately as the global head of Health Economics and served as Chairman of BB Biotech, Bioxell SpA, Intercell AG, as founding chairman of Okairos, founding vice-chairman of Biovertis and chairman of Vaximm. From 2010 to 2025 he has been chairman of the largest Swiss healthcare insurer, Helsana Group and chaired the board of Solida Insurance AG. From 2020 to 2025, he serves on the Board of the Kantonsspital in Uri and on the board of ZADZ Center for Anxiety and Depression Zurich.

He holds a medical degree from the University of Basel, a Master in Business Administration from the University of St Gallen, a Master of Public Health degree from Harvard University, a LL.M in International Business Law from the University of Zurich and a doctorate in law from the Private University of Liechtenstein.

Thomas is board certified in Pharmaceutical Medicine as well as in Prevention and Public Health. He has published more than 500 articles, book chapters and monographies. He has worked extensively in the field of pharmaceutical economics and epidemiology. In 2013 he started a small practice in personalized medicine with special emphasis on pharmacogenomics at the Klinik Hirslanden in Zurich. 

He was rated among the 20 most influential economists in Switzerland in 2016.